While many studies have examined the associations of subjective cognitive decline—especially subjective memory concerns (SMC)—and objective subtle cognitive decline (Obj-SCD) with amyloid [3–7], there has been limited research examining the associations of these classifications with in vivo measures of tau, particularly tau positron emission tomography (PET). This evidence concerns the gene MAPT and Mental deterioration.